BlackRock, Inc. 13D and 13G filings for Viridian Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-29 3:26 pm Purchase | 2023-12-31 | 13G | VIRIDIAN THERAPEUTICS INC VRDN | BlackRock Inc. BLK | 3,426,450 6.500% | 664,894 (+24.08%) | Filing |
| 2023-02-03 12:10 pm Purchase | 2022-12-31 | 13G | VIRIDIAN THERAPEUTICS INC VRDN | BlackRock Inc. BLK | 2,761,556 6.900% | 2,761,556 (New Position) | Filing |